Publications by authors named "Gauthier Flahaut"
Given the risk of rejection, the presence of preformed donor specific antibodies (DSA) contraindicates transplantation in most allocation systems. However, HLA-Cw and -DP DSA escape this censorship. We performed a multicentric observational study, in which the objective was to determinate risk factors of acute antibody-mediated rejection (aABMR) in recipients transplanted with preformed isolated Cw- or DP-DSA.
View Article and Find Full Text PDFArticle Synopsis
- Kidney transplant recipients (KTRs) show a weak humoral response to COVID-19 vaccines, and the specific factors affecting this response to three vaccine doses are still unclear.
- A study at Amiens University Hospital analyzed KTRs and found that 66.3% were seropositive while only 26.1% had an optimal antibody response; seropositivity was strongly linked to a history of COVID-19.
- Significant non-response factors included being female, time since transplant, higher creatinine levels, and specific immunosuppressive medications.
Background: The aim was to describe the regulatory B and T cells (Breg and Treg) and T helper 17 (Th17) lymphocytes before and under treatment with biologic drugs, and to assess their potential predictive value as biomarkers of response in rheumatoid arthritis (RA).
Methods: This was a non-randomised, single-centre, prospective study. Patients with active RA (American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) 2010) who required the initiation or switch to any biologic drug except rituximab were included.
BK virus is a common opportunistic post-transplantation viral infection. Although some risk factors have been studied in this context, the contribution of NK cells has not been assessed in detail. In a group of kidney transplant recipients, we studied the association between (i) the likelihood of BK virus replication during the two-year period after kidney transplantation and (ii) the genotypes of the killer cell immunoglobulin-like receptor (KIR) repertoire and their human leukocyte antigen (HLA) ligands.
View Article and Find Full Text PDF